
GSK Investors Suffering Significant Losses Urged to Contact Rosen Law Firm for Information on Potential Securities Class Action
Rosen Law Firm Announces Investigation into Alleged Securities Fraud at GSK plc NEW YORK, NY – In a recent press release, Rosen Law Firm, a renowned global investor rights law firm, announced that it had commenced an investigation into potential securities fraud claims against GSK plc (NYSE: GSK). The investigation pertains to purchasers of American…